UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Discover various ways to boost quick earnings that can enhance your income. Take action now and earn more!
20,595 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A prominent fiduciary family office recently exited a sizable international value ETF position, prompting questions a...
A Florida biologist and state agency reach a $485,000 settlement over her firing tied to social media comments about ...
Emerging markets can surprise investors with big moves. This article explains how a notable fund outpaced its benchma...
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
In 2026, investors face a pivotal choice between the world's largest gold producer and a nimble challenger. This arti...
Five weeks after Vanguard split three ETFs, VGT led the gauges, turning a post-split move into a meaningful performan...
In a market thirsting for the next big tech winner, the steady power of dividend growth often goes unseen. This artic...
A 60-year-old investor with $4 million in net worth weighs buying a $400,000 boat, testing whether income or net wort...
Markets remain choppy as 2026 unfolds. This article lays out practical steps to shield portfolios and stay resilient ...
A lightweight but powerful AI platform is emerging as the newest winner cheaper than Anthropic, with early profitabil...
Leaders face a shifting landscape as corporate confidence hits multi-year lows, echoing Michelle Obama’s blunt remind...